Drug recall · April 29, 2026
Omega-3-Acid recall
Why: Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06
- Lots / codes
Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026
- Quantity
- 2,238 5 x 10 unit dose cartons
- Company
- The Harvard Drug Group LLC, Dublin, OH
- Distribution
- Nationwide in the USA
- Initiated
- April 9, 2026 · Voluntary: Firm initiated
- Classified
- April 24, 2026
- Reported
- April 29, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Omega-3 acid ethyl esters (USP)
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.